http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102005008765-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ddcb273a108a5d8472b335280098e06 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B40-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1037 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18 |
| filingDate | 2005-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_472c4e3691ca2f61126de59d6a64229a |
| publicationDate | 2006-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-102005008765-A1 |
| titleOfInvention | Bacteriophage-based contrast agents, use and process for their preparation |
| abstract | ThenThe present invention relates to novel contrast agents on the basisnof bacteriophages and process for their preparation. The bacteriophagesn(1) include a first fusion protein which is a phage surface proteinn(5) and one forna target structure to be detected (8) comprises specific ligands (6), andna second fusion protein which is a phage surface proteinn(3) and a peptide which bind to a signaling molecule (4)ncan. |
| priorityDate | 2005-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.